Publication | Closed Access

Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma

Tumor BiologyPancreatic CancerMedicineAdjuvant ChemotherapyPathologyPancreatic SurgeryResected Pancreatic AdenocarcinomaImmune Checkpoint InhibitorDisease Progression PatternOncologyRadiation OncologyTumor MicroenvironmentCancer Research